✅ Product Benefits

1. Targeted COX‑2 inhibition with reduced GI risk — Etoricoxib selectively inhibits COX‑2 to reduce pain and inflammation while sparing COX‑1, lowering gastrointestinal side effect risk compared to non-selective NSAIDs 

2. Once‑daily dosing convenience — 90 mg once daily enhances compliance, ideal for managing chronic conditions such as rheumatoid arthritis or ankylosing spondylitis 

3. Rapid onset & long duration — Begins working within a few hours; half-life of ~22 hours supports sustained pain control with once-daily dosing 

4. Wide spectrum indications — Approved for osteoarthritis, rheumatoid arthritis, ankylosing spondylitis (90 mg); acute gouty arthritis (120 mg); postoperative dental pain (up to 3 days at 90 mg) 

5. Flexible administration — Can be taken with or without food, offering greater convenience and consistent absorption .

6. Lower GI side effects & bleeding risk — Lower impact on platelet function and gastric mucosa compared to traditional NSAIDs; beneficial for patients at higher GI risk

7. Well‑defined safety monitoring guidelines — Use with caution in patients with cardiovascular disease, hypertension, renal or hepatic impairment; regular monitoring recommended; contraindicated in pregnancy, significant heart failure, severe renal or hepatic dysfunction, IBD, and in those under 16